Literature DB >> 29027539

Fatigue as a symptom or comorbidity of neurological diseases.

Iris-Katharina Penner1,2, Friedemann Paul3,4.   

Abstract

Fatigue, best described as an overwhelming feeling of tiredness and exhaustion, occurs in the context of various neurological diseases. The high prevalence of fatigue as either a symptom or a comorbidity of neurological disease must be taken seriously, as fatigue interferes with patients' activities of daily living, has a remarkable negative impact on quality of life, and is a major reason for early retirement. The tremendous consequences of fatigue are consistent across neurological diseases, as is the uncertainty concerning its underlying pathophysiological mechanisms. Inconsistencies in defining fatigue contribute to the present situation, in which fatigue represents one of the least-studied and least- understood conditions. Tools for assessing fatigue abound, but few can be recommended for clinical or research use. To make matters worse, evidence-based pharmacological treatment options are scarce. However, non-pharmacological approaches are currently promising and likely to become of increasing importance. In sum, fatigue is challenging for both health-care professionals and patients. The present article aims to provide a comprehensive review of the literature on fatigue in neurological disease, and to reveal its complexity, as well as weaknesses in the concept of fatigue itself.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29027539     DOI: 10.1038/nrneurol.2017.117

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  171 in total

Review 1.  Amantadine for fatigue in multiple sclerosis.

Authors:  E Pucci; P Branãs; R D'Amico; G Giuliani; A Solari; C Taus
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  The Self-Directed Biological Transformation Initiative and Well-Being.

Authors:  Paul J Mills; Kathleen L Wilson; Meredith A Pung; Lizabeth Weiss; Sheila Patel; P Murali Doraiswamy; Christine Peterson; Valencia Porter; Eric Schadt; Deepak Chopra; Rudolph E Tanzi
Journal:  J Altern Complement Med       Date:  2016-06-28       Impact factor: 2.579

3.  Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis.

Authors:  Orjana Velikonja; Katarina Curić; Ana Ozura; Sasa Sega Jazbec
Journal:  Clin Neurol Neurosurg       Date:  2010-04-04       Impact factor: 1.876

4.  The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study.

Authors:  S B Harvey; M Wadsworth; S Wessely; M Hotopf
Journal:  Psychol Med       Date:  2007-11-02       Impact factor: 7.723

5.  Modafinil May Alleviate Poststroke Fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial.

Authors:  Mai Bang Poulsen; Bodil Damgaard; Bo Zerahn; Karsten Overgaard; Rune Skovgaard Rasmussen
Journal:  Stroke       Date:  2015-11-03       Impact factor: 7.914

6.  Impact of fatigue on quality of life in patients with Parkinson's disease.

Authors:  E Havlikova; J Rosenberger; I Nagyova; B Middel; T Dubayova; Z Gdovinova; J P van Dijk; J W Groothoff
Journal:  Eur J Neurol       Date:  2008-03-05       Impact factor: 6.089

7.  Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach.

Authors:  Mauro Catalan; Alessandra De Michiel; Alessio Bratina; Susanna Mezzarobba; Lorella Pellegrini; Roberto Marcovich; Francesca Tamiozzo; Giovanna Servillo; Laura Zugna; Antonio Bosco; Arianna Sartori; Gilberto Pizzolato; Marino Zorzon
Journal:  Rehabil Res Pract       Date:  2011-09-08

8.  Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial.

Authors:  Thomas Lillicrap; Venkatesh Krishnamurthy; John Attia; Michael Nilsson; Christopher R Levi; Mark W Parsons; Andrew Bivard
Journal:  Trials       Date:  2016-08-17       Impact factor: 2.279

9.  Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.

Authors:  Sarah Hoffmann; Jana Siedler; Alexander U Brandt; Sophie K Piper; Siegfried Kohler; Christian Sass; Friedemann Paul; Ralf Reilmann; Andreas Meisel
Journal:  BMC Neurol       Date:  2015-12-23       Impact factor: 2.474

10.  Self-Reported Fatigue and Associated Factors Six Years after Stroke.

Authors:  Marie Elf; Gunilla Eriksson; Sverker Johansson; Lena von Koch; Charlotte Ytterberg
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

View more
  66 in total

1.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

2.  Fatigue in patients with myasthenia gravis.

Authors:  T M Alekseeva; Y V Gavrilov; O A Kreis; P O Valko; K P Weber; Y Valko
Journal:  J Neurol       Date:  2018-08-11       Impact factor: 4.849

3.  Fatigue in multiple sclerosis is associated with multimodal interoceptive abnormalities.

Authors:  Cecilia Gonzalez Campo; Paula C Salamone; Nicolás Rodríguez-Arriagada; Fabian Richter; Eduar Herrera; Diana Bruno; Fátima Pagani Cassara; Vladimiro Sinay; Adolfo M García; Agustín Ibáñez; Lucas Sedeño
Journal:  Mult Scler       Date:  2019-11-28       Impact factor: 6.312

4.  Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis.

Authors:  Gabriela Magalhães Pereira; Jefferson Becker; Nayron Medeiros Soares; Lucas Araújo de Azeredo; Rodrigo Grassi-Oliveira; Andreo Rysdyk; Rosa Maria Martins de Almeida
Journal:  J Neural Transm (Vienna)       Date:  2019-06-27       Impact factor: 3.575

5.  The association between fatigue severity and risk of falls among middle-aged and older Australian stroke survivors.

Authors:  David Sibbritt; Jessica Bayes; Wenbo Peng; Jane Maguire; Suzy Ladanyi; Jon Adams
Journal:  Aging Clin Exp Res       Date:  2022-07-07       Impact factor: 3.636

Review 6.  Sex differences in autoimmune disorders of the central nervous system.

Authors:  Stefan M Gold; Anne Willing; Frank Leypoldt; Friedemann Paul; Manuel A Friese
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

7.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

8.  Fatigue After Aneurysmal Subarachnoid Hemorrhage: Clinical Characteristics and Associated Factors in Patients With Good Outcome.

Authors:  Elin Western; Tonje Haug Nordenmark; Wilhelm Sorteberg; Tanja Karic; Angelika Sorteberg
Journal:  Front Behav Neurosci       Date:  2021-05-12       Impact factor: 3.558

Review 9.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

10.  Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients.

Authors:  Yesim Beckmann; Sabiha Türe; Sule Uysal Duman
Journal:  EPMA J       Date:  2019-11-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.